Krieglsteiner Susanne, Gümbel Herrmann O C, Kohnen Thomas
Johann-Wolfgang-Goethe-Universität, Zentrum für Augenheilkunde, Frankfurt am Main.
Klin Monbl Augenheilkd. 2004 Jan;221(1):40-6. doi: 10.1055/s-2003-812636.
In HIV-positive patients with necrotising retinitis, well-tolerated lens material as well as minimal invasive surgery to avoid postoperative complications are imperative. Heparin surface-modified PMMA-IOLs as well as acrylic IOLs are associated with less postoperative inflammation than conventional intraocular lenses.
In this randomised prospective clinical trial 18 patients received 7 HSM-IOLs through a self-sealing scleral tunnel and 11 foldable Acrysof-IOLs through a self-sealing limbal tunnel incision by the same surgeon. 7 of the 18 eyes were silicone oil-filled before cataract surgery, one eye received oil after the IOL implantation. Visual acuity, intraocular pressure, contrast sensitivity, intraocular inflammation and posterior capsule opacification were assessed. The follow-up period was 1 year.
Eyes with Acrysof-IOLs were associated with lower, but not statistically significant, laser flare photometry values (photon counts/ms) than those with HSM-IOLs pre- (90.18 +/- 54.7 vs. 73.92 +/- 6.44) and 3 months post-surgery (69.06 +/- 8.27 vs. 55.03 +/- 7.75). 6 of the 7 eyes with HSM-IOL and 3 eyes of the Acrysof-group developed a dense posterior capsule opacification (PCO), 2 eyes had no and 6 eyes only a distinct PCO. YAG capsulotomy did not improve visual acuity in any case but retinal examination was again possible. Eyes with Acryl-IOL showed pre- and postoperatively a better visual acuity than eyes with HSM-IOL ("hand movement" - 0.4 vs. "no light perception" - 0.1 pre- and 0.05 - 0.6 vs. "no light perception" - 0.1 3 months postoperatively. Contrast sensitivity testing (Vistech method) could be performed in the PMMA-group preoperatively only in 1 eye (A1), in the Acryl-group in 2 eyes (A4, B4, C2, D2) and revealed postoperatively "no contrast vision" - A1, B2, C1 vs. "no contrast vision" - A2, B2, C3, D1, E1. The intraocular pressure was preoperatively 13.86 mm Hg (PMMA) vs. 14.82 mm Hg (Acrysof) and 14.4 mm Hg vs. 12.89 mm Hg 3 months post surgery.
In the parameters we observed there was no statistical significant difference between heparin-surface modified (Pharmacia 811 C) and hydrophobic acrylic IOLs (Alcon Acrysof MA60BM) in patients with AIDS. As foldable Acrysof-IOLs can be implanted through a self-sealing bloodless tunnel incision and are associated with less posterior capsule opacification we prefer this IOL type in cataract surgery of AIDS patients.
对于患有坏死性视网膜炎的HIV阳性患者,必须使用耐受性良好的晶状体材料以及采用微创手术以避免术后并发症。肝素表面改性的聚甲基丙烯酸甲酯人工晶状体(HSM-IOL)以及丙烯酸人工晶状体与传统人工晶状体相比,术后炎症反应更少。
在这项随机前瞻性临床试验中,同一位外科医生通过自密封巩膜隧道为18例患者植入7枚HSM-IOL,通过自密封角膜缘隧道切口为11例患者植入11枚可折叠的爱尔康Acrysof人工晶状体。18只眼中有7只在白内障手术前已填充硅油,1只眼在人工晶状体植入后填充了硅油。评估了视力、眼压、对比敏感度、眼内炎症和后囊膜混浊情况。随访期为1年。
植入Acrysof人工晶状体的眼在术前(90.18±54.7对73.92±6.44)和术后3个月(69.06±8.27对55.03±7.75)的激光散射光度测量值(光子计数/毫秒)低于植入HSM-IOL的眼,但差异无统计学意义。植入HSM-IOL的7只眼中有6只以及Acrysof组的3只眼出现了致密的后囊膜混浊(PCO),2只眼未出现PCO,6只眼仅有明显的PCO。YAG激光后囊膜切开术在任何情况下均未改善视力,但再次能够进行视网膜检查。植入丙烯酸人工晶状体的眼在术前和术后的视力均优于植入HSM-IOL的眼(术前“手动”视力——0.4对“无光感”——0.1,术后3个月0.05 - 0.6对“无光感”——0.1)。对比敏感度测试(Vistech方法)在PMMA组术前仅1只眼(A1)能够进行,在丙烯酸组2只眼(A4、B4、C2、D2)能够进行,术后显示“无对比视力”——A1、B2、C1对“无对比视力”——A2、B2、C3、D1、E1。术前眼压为13.86毫米汞柱(PMMA)对14.82毫米汞柱(Acrysof),术后3个月为14.4毫米汞柱对12.89毫米汞柱。
在我们观察的参数方面,艾滋病患者中肝素表面改性(法玛西亚811C)和疏水丙烯酸人工晶状体(爱尔康Acrysof MA60BM)之间无统计学显著差异。由于可折叠的Acrysof人工晶状体可通过自密封无血隧道切口植入且后囊膜混浊较少,我们在艾滋病患者白内障手术中更倾向使用这种人工晶状体类型。